Collegium Pharmaceutical, Inc. · NASDAQ:COLL
Invesco Ltd. reported a 5.00% stake in Collegium Pharmaceutical, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 8, 2026
Invesco Ltd. reported a 5.00% stake in Collegium Pharmaceutical, Inc., 1,591,909 shares, as a passive investor on Mar 31, 2026. Filed May 8, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 1,591,909
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Invesco Ltd. | 5.00% | 1,591,909 |
Source
Related
- Collegium Pharmaceutical, Inc.
- Invesco Ltd.
- Collegium Pharmaceutical, Inc. shareholders
- Schedule 13G/A · Invesco Ltd. · Aug 7, 2025
- Schedule 13G · Invesco Ltd. · Feb 7, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 8, 2026
- Schedule 13G · Millennium Management LLC · Aug 24, 2026
- Schedule 13G · Fuller & Thaler Asset Management, Inc. · Aug 14, 2026
- Schedule 13G · Principal Global Investors · Aug 5, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026